Company: BLCO
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0001860742-25-000018
Chunk: 53

Company: Bausch & Lomb Corp
Filing Date: 2025-07-30
Form: 10-Q
Item: Item 8
Chunk 53
---
Interest income3 3 Interest expense(128)(102)Loss on extinguishment of debt(9)— Foreign exchange and other (2)(3)Loss before provision for income taxes$(147)$(76)Vision CarePharmaceuticalsSurgicalTotalSix Months Ended June 30,(in millions)20252024202520242025202420252024RevenuesProduct Sales$1,405 $1,328 $573 $576 $427 $403 $2,405 $2,307 Other Revenues4 4 3 1 3 3 10 8 1,409 1,332 576 577 430 406 2,415 2,315 ExpensesCost of goods sold (excluding amortization and impairments of intangible assets)541 483 197 181 266 241 Cost of other revenues— — 3 2 — — Selling, general and administrative464 455 307 248 146 131 Research and development19 24 21 15 23 19 Segment Profit$385 $370 $48 $131 $(5)$15 428 516 Corporate(344)(313)Amortization of intangible assets(134)(148)Other expense, net(44)(23)Operating (loss) income(94)32 Interest income6 6 Interest expense(222)(201)Loss on extinguishment of debt(9)— Foreign exchange and other (8)(3)Loss before provision for income taxes$(327)$(166)

29

Revenues by Segment and by Product CategoryRevenues by segment and product category were as follows:Vision CarePharmaceuticalsSurgicalTotalThree Months Ended June 30,(in millions)20252024202520242025202420252024Pharmaceuticals$1 $1 $259 $244 $— $— $260 $245 Devices258 237 — — 214 208 472 445 OTC482 447 — — — — 482 447 Branded and Other Generics10 10 48 66 — — 58 76 Other revenues2 2 2 — 2 1 6 3 $753 $697 $309 $310 $216 $209 $1